PAR 2.08% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Receives $7.36m R&D Tax Incentive Refund, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,907 Posts.
    lightbulb Created with Sketch. 7132
    Wasn't guidance $8-11m?

    "Forecast cash outflow for the March 2024 quarter is expected to be $8 - $11m (including R&D refund) and the June 2024 quarter expected to be in the $6m - $8m range which is inclusive of phase 3 stage 2 restart costs." (December qtrly)

    Hopefully the final upfront cash flows with trials reiterated in the recent quarterly flowing out early in the quarter and nothing more....
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
0.005(2.08%)
Mkt cap ! $85.73M
Open High Low Value Volume
24.0¢ 25.0¢ 23.0¢ $180.4K 746.9K

Buyers (Bids)

No. Vol. Price($)
4 79748 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 22818 4
View Market Depth
Last trade - 16.10pm 14/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.